Champions Oncology, Inc. (CSBR)Healthcare | Biotechnology | Hackensack, United States | NasdaqCM
4.93 USD
-0.09
(-1.793%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 4.93 |
Hot Take ↕ | Aug. 22, 2026, 2:49 a.m. EDT
The immediate outlook is bearish, driven by a deteriorating balance sheet and negative free cash flow that suggests the company is burning capital without generating returns. While the stock recently rallied 73% year-over-year, the underlying fundamentals remain fragile with negative operating margins and a high debt-to-equity ratio relative to its small market cap. The options market confirms this fear, with traders aggressively buying protection at low strikes while ignoring the upside potential. Although the long-term price trajectory shows a net gain over nine years, the lack of dividends and the current operational bleed prevent any bullish conviction. The statistical forecast models a slight decline, which aligns with the fundamental weakness, reinforcing a neutral-to-bearish stance. |
| Model | MAE |
|---|---|
| MSTL_79 ✓ | 0.056170 |
| AutoTheta | 0.059053 |
| AutoARIMA | 0.061277 |
| AutoETS | 0.061279 |
| MSTL | 0.062513 |
| MSTL_79_126 | 0.097383 |
| MSTL_126 | 0.128769 |
Forecast horizon: 60 days | Selected: MSTL_79
| Forecast Reliability | |
|---|---|
| Score | 39% |
| H-stat | 2.79 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.714 |
| Excess Kurtosis | -0.12 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 113.029 |
| Revenue per Share | 4.296 |
| Market Cap | 68,495,296 |
| Forward P/E | 49.30 |
| Beta | 0.41 |
| Profit Margins | -1.98% |
| Website | https://www.championsoncology.com |
As of Aug. 22, 2026, 2:49 a.m. EDT: Speculators are positioning for a sharp downside move, evidenced by massive open interest in deep out-of-the-money puts (strike $2.50) compared to negligible call volume. Conversely, there is significant call open interest at the $7.50 strike, suggesting a speculative bet on a recovery to previous highs, though this is outweighed by the put volume. Implied volatility is extremely skewed, with puts trading at 93.5% IV versus calls at 25.5%, indicating the market prices in a high probability of a crash rather than a rally.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.2889518 |
| Address1 | One University Plaza |
| Address2 | Suite 307 |
| All Time High | 25.8 |
| All Time Low | 1.11 |
| Ask | 6.4 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 8,920 |
| Average Daily Volume3 Month | 8,627 |
| Average Volume | 8,627 |
| Average Volume10Days | 8,920 |
| Beta | 0.412 |
| Bid | 3.55 |
| Bid Size | 2 |
| Book Value | 0.284 |
| City | Hackensack |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 4.93 |
| Current Ratio | 0.965 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 5.1 |
| Day Low | 4.93 |
| Debt To Equity | 113.029 |
| Display Name | Champions Oncology |
| Earnings Call Timestamp End | 1,785,184,200 |
| Earnings Call Timestamp Start | 1,785,184,200 |
| Earnings Timestamp | 1,785,182,400 |
| Earnings Timestamp End | 1,789,416,000 |
| Earnings Timestamp Start | 1,789,416,000 |
| Ebitda | 348,000 |
| Ebitda Margins | 0.0058600004 |
| Enterprise To Ebitda | 196.409 |
| Enterprise To Revenue | 1.15 |
| Enterprise Value | 68,350,296 |
| Eps Forward | 0.1 |
| Eps Trailing Twelve Months | -0.08 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 5.6572 |
| Fifty Day Average Change | -0.72720003 |
| Fifty Day Average Change Percent | -0.12854417 |
| Fifty Two Week Change Percent | -28.895182 |
| Fifty Two Week High | 8.74 |
| Fifty Two Week High Change | -3.81 |
| Fifty Two Week High Change Percent | -0.43592677 |
| Fifty Two Week Low | 4.83 |
| Fifty Two Week Low Change | 0.099999905 |
| Fifty Two Week Low Change Percent | 0.020703914 |
| Fifty Two Week Range | 4.83 - 8.74 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,170,426,600,000 |
| Float Shares | 6,077,742 |
| Forward Eps | 0.1 |
| Forward P E | 49.3 |
| Free Cashflow | -4,291,125 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 214 |
| Fullday Change | -0.0900002 |
| Fullday Change Percent | -1.79283 |
| Fullday Price | 4.93 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.48002 |
| Gross Profits | 28,525,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.26659 |
| Held Percent Institutions | 0.42458 |
| Implied Shares Outstanding | 13,893,569 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,777,507,200 |
| Last Split Date | 1,439,337,600 |
| Last Split Factor | 1:12 |
| Long Business Summary | Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice through TumorGraft Technology Platform. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey. |
| Long Name | Champions Oncology, Inc. |
| Market | us_market |
| Market Cap | 68,495,296 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_323655 |
| Most Recent Quarter | 1,777,507,200 |
| Net Income To Common | -1,175,000 |
| Next Fiscal Year End | 1,809,043,200 |
| Non Diluted Market Cap | 69,745,716 |
| Open | 5.1 |
| Operating Cashflow | -4,472,000 |
| Operating Margins | -0.03766 |
| Payout Ratio | 0.0 |
| Phone | 201 808 8400 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 4.93 |
| Post Market Time | 1,787,947,804 |
| Previous Close | 5.02 |
| Price Hint | 4 |
| Price To Book | 17.359154 |
| Price To Sales Trailing12 Months | 1.1526344 |
| Profit Margins | -0.01977 |
| Quick Ratio | 0.906 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0900002 |
| Regular Market Change Percent | -1.79283 |
| Regular Market Day High | 5.1 |
| Regular Market Day Low | 4.93 |
| Regular Market Day Range | 4.93 - 5.1 |
| Regular Market Open | 5.1 |
| Regular Market Previous Close | 5.02 |
| Regular Market Price | 4.93 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 5,142 |
| Return On Assets | -0.02168 |
| Return On Equity | -0.29974002 |
| Revenue Growth | 0.12 |
| Revenue Per Share | 4.296 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 13,893,569 |
| Shares Percent Shares Out | 0.0053 |
| Shares Short | 73,998 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 75,566 |
| Short Name | Champions Oncology, Inc. |
| Short Percent Of Float | 0.0109 |
| Short Ratio | 6.51 |
| Source Interval | 15 |
| State | NJ |
| Symbol | CSBR |
| Total Cash | 4,872,000 |
| Total Cash Per Share | 0.351 |
| Total Debt | 4,598,000 |
| Total Revenue | 59,425,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.08 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 6.13995 |
| Two Hundred Day Average Change | -1.20995 |
| Two Hundred Day Average Change Percent | -0.19706187 |
| Type Disp | Equity |
| Volume | 5,142 |
| Website | https://www.championsoncology.com |
| Zip | 7,601 |